78 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... Infections #OIs #HIVAIDS ... #IDSA #management
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Recommendations for the Treatment ... Aspergillosis - IDSA ... or colonizing syndromes ... Aspergillosis #Treatment ... #medications #IDSA
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
BEE Syndromes - Immune-mediated conditions affecting the brain, eye, and ear

Visual or auditory symptoms in conjunction
BEE Syndromes - ... diagnosis and treatment ... causes: • Susac syndrome ... • Sjögren syndrome ... #neurology #inflammatory
Microbial Etiology of Acute Pharyngitis - IDSA
Bacterial
 • Group A streptococcus - Pharyngotonsillitis, scarlet fever
 •
Pharyngitis - IDSA ... necrophorum - Lemierre’s syndrome ... Herpes simplex virus ... #Pharyngitis #IDSA
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... candida #mucosal #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Pharmacological Treatment ... of Hepatorenal Syndrome ... #HepatoRenal #Syndrome ... #Nephrology #Management ... #Medications #Treatment